Table 1.
INR, LAC and anticardiolipin antibodies (9 August 2001)
| Patient | Normal range | |
|---|---|---|
| INR | 3.63 | <1 (%) |
| PTT | >120 | 31–42 s |
| KCT | positive | |
| ICA | 42.8 | 0–15 |
| IgG-aCL | 42.5 | 0.9–11.7 (GPL-U/ml) |
| IgM-aCL | 9.9 | 0.3–4.8 (MPL-U/ml) |
| β2-GP-1 | positive |
INR, LAC and anticardiolipin antibodies (9 August 2001)
| Patient | Normal range | |
|---|---|---|
| INR | 3.63 | <1 (%) |
| PTT | >120 | 31–42 s |
| KCT | positive | |
| ICA | 42.8 | 0–15 |
| IgG-aCL | 42.5 | 0.9–11.7 (GPL-U/ml) |
| IgM-aCL | 9.9 | 0.3–4.8 (MPL-U/ml) |
| β2-GP-1 | positive |